Ann: Appendix 4E & Annual Report, page-20

I don’t disagree with that. The issue I have is they shot themselves in both feet. Returning excess cash then sinking SP should have raised earlier.

Either redirect cash to program that will get that notice then raise. Or continue programs in parallel and raise at stupid price.

We need some runs on the board, consolidate program focus or give some IP away in terms of AML or ALKBH5 to fund. Or dilute like crazy as a last resort, only a fan once other avenues are exhausted.

But in short 100% agree need to make some waves and if they can do that without time burn or dillution then great. If not have to bit the bullet IMO.

Each year of patent life NPV depletes, so there is an opportunity cost to move forward.